Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrazine | HCID 9321 | — |
| Reactant | HCID 11444703 | HCID 11444703 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 11453978 | HCID 11453978 | 65.1% |
Reaction Steps
To a suspension of 420 mg (0.7 mmol) of (RS,SR)-2-{5-[benzenesulfonyl-(7-chloro-1,2,3,4-tetrahydro-cyclopenta[b]indol-2-yl)-fluoro-methyl]-[1,2,4]oxadiazol-3-ylmethyl}-isoindole-1,3-dione in 50 mL EtOH at RT, was added 0.1 mL (2.1 mmol, 3 eq) hydrazine. The reaction mixture was heated at 80° C. over 3 hours 30 minutes. After cooling down, the reaction was quenched with a 1M solution of HCl, and extracted with EtOAc. The combined organic phases were dried over Na2SO4, filtered and evaporated. Column chromatography on silica gel (CH2Cl2/MeOH 95/5) yielded 210 mg (64%) of (RS,SR)-C-{5-[benzenesulfonyl-(7-chloro-1,2,3,4-tetrahydro-cyclopenta[b]indol-2-yl)-fluoro-methyl]-[1,2,4]oxadiazol-3-yl}-methylamine as a light brown powder, MS: 461 (MH+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07906546B2 |
|---|
| Source dataset | uspto-grants-2011_03 |
|---|
| ORD ID | ord-87d986684bbd468da45eff18d37c1c1b |
|---|
| Source note | uspto-grants-2011_03 |
|---|